Progress in Gynecologic Oncology-Reference-Cited by-同舟云学术

Progress in Gynecologic Oncology

Published:1999-08-01 Issue:4 Volume:4 Page:293-298
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Penson Richard T.¹,Seiden Michael V.¹

Affiliation:

1. Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.4-4-293

Reference27 articles.

1. Randomized, controlled trial of high-dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer;Bezwoda;Proc Am Soc Clin Oncol,1999

2. Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group Trial (GOG 158);Ozols;Proc Am Soc Clin Oncol,1999

3. Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group;Gore;J Clin Oncol,1998

4. Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group Study;Jakobsen;J Clin Oncol,1997

5. Cisplatin/paclitaxel vs. carboplatin/paclitaxel in ovarian cancer: update of an Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Study Group Trial;Du Bois;Proc Am Soc Clin Oncol,1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin Enhances Oral Bioavailability and Anti-Tumor Therapeutic Efficacy of Paclitaxel upon Administration in Nanoemulsion Formulation;Journal of Pharmaceutical Sciences;2010-11

2. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer;International Journal of Cancer;2007

3. A phase II study of fixed dose rate gemcitabine in patients with relapsed mullerian tumors;International Journal of Gynecological Cancer;2005-11

4. Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure;Ultrasonics Sonochemistry;2004-07

5. A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent m�llerian tumors;Cancer;2001